Dr. Pryce Tiffany Gaynor, MD

Dr. Gaynor practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Gaynor's NPI, 1972916955, was assigned on June 6, 2014. Dr. Gaynor holds California license A147971.

Dr. Gaynor's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Gaynor's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Gaynor to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gaynor practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Gaynor's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Gaynor is licensed in California.

CMS data shows 846 Medicare services from Dr. Gaynor across 4 procedure codes in 2024, for 184 Medicare patients. Medicare paid $90,086 for them.

CMS counts 184 Medicare patients who saw Dr. Gaynor in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 53% are also on Medicaid. Their average risk score is 5.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gaynor's median patient age at 59, with 42% women.

In 2024, Dr. Gaynor wrote 154 Medicare Part D claims for 39 patients. 75% of them were for generic drugs. CMS names the drug for 78 of them, across 5 drugs with 11 or more claims each, at $133,955 in total drug cost. In 2023, CMS named 76 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Gaynor for performance year 2024, reported as part of a group. Dr. Gaynor accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gaynor as offering telehealth.

Dmand AI links 4 papers to Dr. Gaynor, published from 2018 to 2021. 2018 was the busiest year, with 2. Dr. Gaynor's most frequent co-authors are Norman Laurence Beatty, MD, Anca D. Georgescu, MD and Ramy Magdy Hanna, MD.

CMS Open Payments shows 12 general payments to Dr. Gaynor from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 97% of the total. La Jolla Pharmaceutical Company paid the most, $313.